ストックスクリーナーアプリを入手
3.07
0.97%
-0.03
アフターアワーズ：
3.07
前日終値:
$3.10
開ける：
$3.14
24時間の取引高:
161.30K
Relative Volume:
0.51
時価総額：
$118.45M
収益：
-
当期純損益:
$-42.05M
株価収益率:
-1.0887
EPS:
-2.82
ネットキャッシュフロー:
$-35.26M
1週間 パフォーマンス:
-2.54%
1か月 パフォーマンス:
+0.66%
6か月 パフォーマンス:
-26.02%
1年 パフォーマンス:
+58.25%
1日の値動き範囲:
$3.0101
$3.1516
1週間の範囲:
$3.01
$3.21
52週間の値動き範囲:
$1.595
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
名前
Protara Therapeutics Inc
セクター
電話
646-844-0337
住所
345 PARK AVENUE SOUTH, NEW YORK, NY
TARA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
3.07 | 119.60M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-16 | 開始されました | Scotiabank | Sector Outperform |
| 2025-03-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-07-10 | 再開されました | Guggenheim | Buy |
| 2021-06-04 | 開始されました | H.C. Wainwright | Buy |
| 2021-02-17 | 開始されました | Oppenheimer | Outperform |
| 2020-10-19 | 開始されました | Cowen | Outperform |
| 2020-07-29 | 開始されました | Guggenheim | Buy |
すべてを表示
Protara Therapeutics Inc (TARA) 最新ニュース
Protara Therapeutics Reports Q2 2025 Financial Results - MSN
Backtesting results for Protara Therapeutics Inc. trading strategiesWeekly Return Plan for Conservative Traders - Newser
Published on: 2025-08-12 02:18:08 - Newser
Smart tools for monitoring Protara Therapeutics Inc.’s price actionFree Sector Based Breakout Stock Forecast - Newser
Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Is Protara Therapeutics Inc. in a bullish channelHigh Growth With Low Risk - mustnews.co.kr
Using data filters to optimize entry into Protara Therapeutics Inc.Growth Projection Summary for Long-Term Investors - Newser
Applying big data sentiment scoring on Protara Therapeutics Inc.Free Growth Focused Entry Plan Suggestions - Newser
Protara Therapeutics: Q2 Earnings Snapshot - San Antonio Express-News
Protara Therapeutics reports Q2 EPS (35c), consensus (38c) - TipRanks
Protara’s Losses Grew But Wall Street’s Still On Board - Finimize
Protara Beats Q2 Loss Estimates - The Motley Fool
Protara Therapeutics Q2 2025 Financial Results and Business Update - TradingView
Protara Therapeutics' Q2 net loss widens - MarketScreener
Protara Therapeutics, Inc. SEC 10-Q Report - TradingView
Protara (TARA) Announces Q2 2025 Results; Press Release Furnished | TARA SEC FilingForm 8-K - Stock Titan
Protara Therapeutics Reveals Strong $146M Cash Position, Multiple Clinical Milestones Coming in Next 6 Months - Stock Titan
Using RSI to spot recovery in Protara Therapeutics Inc.Equity Portfolio Outlook and Performance Summary - Newser
News impact scoring models applied to Protara Therapeutics Inc.Free Top Gaining Picks With Entry Signals - Newser
Tick level data insight on Protara Therapeutics Inc. volatilityFree Weekly Hot Picks With Buy Confidence - Newser
Understanding Protara Therapeutics Inc.’s price movementMomentum Detection with Entry Optimization - Newser
Published on: 2025-08-10 02:01:28 - Newser
How Protara Therapeutics Inc. stock performs during market volatilityFree Pattern Alert With ROI Driven Strategy - Newser
Does Protara Therapeutics Inc. fit your quant trading modelFree Entry Alert With Low Drawdown Strategy - Newser
Protara Therapeutics Inc. stock volume spike explainedPattern Breakout Tracker with Screener Tools - Newser
Combining price and volume data for Protara Therapeutics Inc.Neural Network Based Equity Prediction System - Newser
What earnings revisions data tells us about Protara Therapeutics Inc.Free Trade Setups With AI Powered Filters - Newser
How to build a custom watchlist for Protara Therapeutics Inc.Short-Term AI-Based Stock Price Forecast - Newser
Why Protara Therapeutics Inc. stock attracts strong analyst attentionSmart Entry Signals for Active Traders - Newser
What analysts say about Protara Therapeutics Inc. stockCapitalize on momentum stocks before they peak - Jammu Links News
When is Protara Therapeutics Inc. stock expected to show significant growthTransform your portfolio with high-yield stocks - Jammu Links News
How does Protara Therapeutics Inc. compare to its industry peersOutstanding trading profits - Jammu Links News
Should I hold or sell Protara Therapeutics Inc. stock in 2025Capitalize on market momentum for big wins - Jammu Links News
What catalysts could drive Protara Therapeutics Inc. stock higher in 2025Free Consultation - Jammu Links News
What are Protara Therapeutics Inc. company’s key revenue driversMaximize portfolio growth with expert advice - Jammu Links News
What are analysts’ price targets for Protara Therapeutics Inc. in the next 12 monthsPhenomenal returns - Jammu Links News
What is Protara Therapeutics Inc. company’s growth strategyGet real-time alerts on top stocks - Jammu Links News
What institutional investors are buying Protara Therapeutics Inc. stockDouble or triple returns - Jammu Links News
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Protara Therapeutics Grants $45K Worth of Stock Options and RSUs to Strategic New Employees - Stock Titan
Protara Therapeutics Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Protara Therapeutics Inc (TARA) 財務データ
収益
当期純利益
現金流量
EPS
0.91%
3.06%
大文字化:
|
ボリューム (24 時間):